X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2267) 2267
Publication (248) 248
Newsletter (44) 44
Book / eBook (18) 18
Book Chapter (9) 9
Book Review (7) 7
Conference Proceeding (2) 2
Dissertation (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2067) 2067
index medicus (1268) 1268
female (911) 911
oncology (906) 906
male (833) 833
cancer (820) 820
kidney neoplasms - enzymology (770) 770
animals (728) 728
carcinoma, renal cell - enzymology (711) 711
middle aged (655) 655
aged (559) 559
cell line, tumor (471) 471
adult (460) 460
kidney neoplasms - pathology (441) 441
expression (440) 440
immunohistochemistry (373) 373
carcinoma, renal cell - pathology (362) 362
tumors (352) 352
mice (347) 347
research (344) 344
carcinoma (322) 322
prognosis (305) 305
apoptosis (289) 289
metastasis (289) 289
cell biology (286) 286
renal cell carcinoma (281) 281
renal-cell carcinoma (279) 279
proteins (272) 272
research article (267) 267
aged, 80 and over (242) 242
medicine (238) 238
gene expression (234) 234
biochemistry & molecular biology (231) 231
gene expression regulation, neoplastic (229) 229
enzymes (226) 226
genetic aspects (224) 224
neoplasms - enzymology (211) 211
pathology (206) 206
kidney neoplasms - genetics (202) 202
care and treatment (200) 200
multidisciplinary sciences (197) 197
carcinoma, renal cell - genetics (192) 192
antineoplastic agents - therapeutic use (187) 187
signal transduction (187) 187
kinases (186) 186
carcinoma, renal cell (185) 185
health aspects (183) 183
antineoplastic agents - pharmacology (180) 180
pharmacology & pharmacy (180) 180
breast-cancer (178) 178
kidney neoplasms - drug therapy (177) 177
analysis (176) 176
science (176) 176
tumor cells, cultured (175) 175
carcinoma, renal cell - drug therapy (174) 174
survival (173) 173
cell proliferation (170) 170
protein kinase inhibitors - therapeutic use (169) 169
development and progression (165) 165
physiological aspects (165) 165
phosphorylation (161) 161
growth (155) 155
treatment outcome (155) 155
urology & nephrology (154) 154
article (152) 152
lung neoplasms - enzymology (148) 148
angiogenesis (145) 145
time factors (145) 145
biomarkers, tumor - metabolism (143) 143
mutation (143) 143
neoplasm staging (141) 141
medicine, research & experimental (139) 139
activation (138) 138
risk factors (137) 137
mice, nude (136) 136
biochemistry (131) 131
cell proliferation - drug effects (130) 130
chemotherapy (128) 128
signal transduction - drug effects (126) 126
neoplasm invasiveness (125) 125
breast cancer (123) 123
inhibition (122) 122
blotting, western (121) 121
apoptosis - drug effects (120) 120
kidney - enzymology (119) 119
liver neoplasms - enzymology (119) 119
carcinoma, hepatocellular - enzymology (116) 116
protein kinase inhibitors - pharmacology (116) 116
transfection (116) 116
studies (115) 115
gene expression regulation, enzymologic (114) 114
genetics (110) 110
hepatocellular-carcinoma (110) 110
metabolism (110) 110
cancer therapies (105) 105
disease-free survival (105) 105
gene (105) 105
gene-expression (105) 105
neoplasms - drug therapy (104) 104
rna, messenger - genetics (102) 102
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2294) 2294
Japanese (15) 15
Spanish (7) 7
Chinese (4) 4
Russian (4) 4
French (3) 3
German (3) 3
Finnish (1) 1
Hungarian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


European Urology, ISSN 0302-2838, 2016, Volume 70, Issue 1, pp. 93 - 105
Abstract The fourth edition of the World Health Organization (WHO) classification of urogenital tumours (WHO “blue book”), published in 2016, contains... 
Urology | Urogenital tract | WHO classification | Male genital organs | SQUAMOUS-CELL-CARCINOMA | TUBULOCYSTIC CARCINOMA | DIFFERENTIATED PAPILLARY MESOTHELIOMA | SPERMATOCYTIC SEMINOMA | PRIMARY PURE TERATOMA | GERM-CELLS | UROLOGY & NEPHROLOGY | GONADAL STROMAL TUMOR | YOLK-SAC TUMOR | IN-SITU | CLINICOPATHOLOGICAL FEATURES | Neoplastic Syndromes, Hereditary - pathology | Uterine Neoplasms - pathology | Carcinoma, Squamous Cell - virology | Humans | Kidney Neoplasms - classification | Carcinoma, Renal Cell - classification | Male | Testicular Neoplasms - pathology | Neoplasm Grading | Leiomyomatosis - pathology | Carcinoma, Renal Cell - enzymology | Uterine Neoplasms - classification | Testicular Neoplasms - classification | Skin Neoplasms - pathology | Penile Neoplasms - virology | Papillomavirus Infections - complications | World Health Organization | Carcinoma, Renal Cell - pathology | Neoplasm Invasiveness | Leiomyomatosis - classification | Succinate Dehydrogenase - deficiency | Skin Neoplasms - classification | Carcinoma, Squamous Cell - classification | Neoplasms, Germ Cell and Embryonal - classification | Kidney Neoplasms - pathology | Penile Neoplasms - classification | Neoplastic Syndromes, Hereditary - classification | Neoplasms, Germ Cell and Embryonal - pathology | Medical colleges | Squamous cell carcinoma | Papillomavirus infections | Tumors
Journal Article
Nature, ISSN 0028-0836, 2014, Volume 513, Issue 7517, pp. 251 - 255
Journal Article
Journal Article
The American Journal of Surgical Pathology, ISSN 0147-5185, 12/2014, Volume 38, Issue 12, pp. 1588 - 1602
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2013, Volume 14, Issue 6, pp. 552 - 562
Journal Article
The American Journal of Human Genetics, ISSN 0002-9297, 06/2013, Volume 92, Issue 6, pp. 974 - 980
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 2014, Volume 32, Issue 8, pp. 760 - 767
Purpose This international phase III trial (Investigating Torisel As Second-Line Therapy [INTORSECT]) compared the efficacy of temsirolimus (mammalian target... 
SURVIVAL | INTERFERON-ALPHA | EVEROLIMUS | ONCOLOGY | BEVACIZUMAB | DOUBLE-BLIND | AGENTS | Niacinamide - analogs & derivatives | TOR Serine-Threonine Kinases - metabolism | Humans | Middle Aged | Male | Protein Kinase Inhibitors - adverse effects | Molecular Targeted Therapy | TOR Serine-Threonine Kinases - antagonists & inhibitors | Young Adult | Receptors, Vascular Endothelial Growth Factor - metabolism | Time Factors | Phenylurea Compounds - adverse effects | Treatment Failure | Aged, 80 and over | Angiogenesis Inhibitors - therapeutic use | Receptors, Vascular Endothelial Growth Factor - antagonists & inhibitors | Adult | Carcinoma, Renal Cell - enzymology | Female | Carcinoma, Renal Cell - drug therapy | Pyrroles - therapeutic use | Angiogenesis Inhibitors - adverse effects | Sirolimus - adverse effects | Sirolimus - analogs & derivatives | Sirolimus - therapeutic use | Kaplan-Meier Estimate | Niacinamide - adverse effects | Niacinamide - therapeutic use | Phenylurea Compounds - therapeutic use | Kidney Neoplasms - mortality | Disease Progression | Carcinoma, Renal Cell - mortality | Disease-Free Survival | Protein Kinase Inhibitors - therapeutic use | Carcinoma, Renal Cell - secondary | Kidney Neoplasms - enzymology | Indoles - therapeutic use | Kidney Neoplasms - pathology | Aged | Kidney Neoplasms - drug therapy | ORIGINAL REPORTS
Journal Article
Oncogene, ISSN 0950-9232, 05/2016, Volume 35, Issue 21, pp. 2687 - 2697
Antiangiogenic therapy resistance occurs frequently in patients with metastatic renal cell carcinoma (RCC). The purpose of this study was to understand the... 
ACTIVATION | METASTASIS | ANGIOGENESIS | BIOCHEMISTRY & MOLECULAR BIOLOGY | CANCER | CELL BIOLOGY | RECEPTOR TYROSINE KINASES | CABOZANTINIB XL184 | ONCOLOGY | C-MET | GROWTH | GENETICS & HEREDITY | EXPRESSION | PROGRESSION | Proto-Oncogene Proteins c-met - metabolism | Humans | Drug Resistance, Neoplasm | Molecular Targeted Therapy | Sunitinib | Receptor Protein-Tyrosine Kinases - antagonists & inhibitors | Carcinoma, Renal Cell - enzymology | Indoles - pharmacology | Carcinoma, Renal Cell - drug therapy | Proto-Oncogene Proteins - metabolism | Proto-Oncogene Proteins - antagonists & inhibitors | Signal Transduction | Carcinoma, Renal Cell - pathology | Proto-Oncogene Proteins c-met - antagonists & inhibitors | Angiogenesis Inhibitors - pharmacology | Proto-Oncogene Proteins - genetics | Receptor Protein-Tyrosine Kinases - metabolism | Proto-Oncogene Proteins c-met - genetics | Xenograft Model Antitumor Assays | Pyrroles - pharmacology | Animals | Receptor Protein-Tyrosine Kinases - genetics | Mice, Nude | Kidney Neoplasms - enzymology | Kidney Neoplasms - pathology | Cell Proliferation - drug effects | Mice | Kidney Neoplasms - drug therapy | Molecular targeted therapy | Genetic aspects | Carcinoma, Renal cell | Drug therapy | Drug resistance | Properties | Phosphotransferases | Methods | Cancer therapies | Kidney cancer | Metastasis | Cabozantinib | Renal Cell Carcinoma | AXL | MET
Journal Article
The American Journal of Surgical Pathology, ISSN 0147-5185, 01/2018, Volume 42, Issue 3, pp. 279 - 292
Renal medullary carcinomas (RMCs) and collecting duct carcinomas (CDCs) are rare subsets of lethal high-stage, high-grade distal nephron-related... 
FH-deficient renal cell carcinoma | morphology | renal medullary carcinoma | hereditary leiomyomatosis and renal cell carcinoma syndrome-associated renal cell carcinoma | collecting duct carcinoma | SURGERY | INTERNATIONAL-SOCIETY | HEREDITARY LEIOMYOMATOSIS | PATHOLOGY | CANCER | PAX8 | MUTATIONS | UTERINE LEIOMYOMAS | EXPRESSION | KIDNEY TUMORS | IMMUNOHISTOCHEMISTRY | Immunohistochemistry | Predictive Value of Tests | Kidney Neoplasms - genetics | United States | Biomarkers, Tumor - deficiency | Humans | Middle Aged | Kidney Neoplasms - classification | Carcinoma, Renal Cell - classification | Carcinoma, Renal Cell - genetics | Male | Fumarate Hydratase - deficiency | Young Adult | Neoplasm Grading | DNA Mutational Analysis | Aged, 80 and over | Brazil | Adult | Carcinoma, Renal Cell - enzymology | Female | Kidney Tubules, Collecting - enzymology | Retrospective Studies | Kidney Medulla - pathology | Child | Diagnosis, Differential | Genetic Predisposition to Disease | Kidney Medulla - enzymology | Carcinoma, Renal Cell - pathology | Europe | Kidney Tubules, Collecting - pathology | Fumarate Hydratase - genetics | Canada | Phenotype | Biopsy | Kidney Neoplasms - enzymology | Adolescent | Kidney Neoplasms - pathology | Aged | Biomarkers, Tumor - genetics | Mutation | Australia | Enzymes | Care and treatment | Oncology, Experimental | Regulation | Carcinoma, Renal cell | Diagnosis | Research | Health aspects | Cancer
Journal Article